Market Cap 354.25M
Revenue (ttm) 90.24M
Net Income (ttm) -263.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -291.99%
Debt to Equity Ratio 0.00
Volume 681,000
Avg Vol 1,446,468
Day's Range N/A - N/A
Shares Out 49.55M
Stochastic %K 36%
Beta 1.28
Analysts Strong Sell
Price Target $36.91

Latest News on RGNX

Regenxbio Inc.: Why It Is Down, And When It Will Go Up Again

Jan 15, 2025, 3:27 PM EST - 2 days ago

Regenxbio Inc.: Why It Is Down, And When It Will Go Up Again


REGENXBIO Inc. (RGNX) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 11:16 PM EST - 2 months ago

REGENXBIO Inc. (RGNX) Q3 2024 Earnings Call Transcript


REGENXBIO to Participate in Upcoming Investor Conferences

Nov 4, 2024, 7:05 AM EST - 2 months ago

REGENXBIO to Participate in Upcoming Investor Conferences


REGENXBIO Appoints Mitchell Chan as Chief Financial Officer

Sep 17, 2024, 7:05 AM EDT - 4 months ago

REGENXBIO Appoints Mitchell Chan as Chief Financial Officer


REGENXBIO Inc. (RGNX) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 11:06 PM EDT - 6 months ago

REGENXBIO Inc. (RGNX) Q2 2024 Earnings Call Transcript


REGENXBIO Announces Leadership Transition

Jun 12, 2024, 7:05 AM EDT - 7 months ago

REGENXBIO Announces Leadership Transition


REGENXBIO Inc. (RGNX) Q1 2024 Earnings Call Transcript

May 8, 2024, 9:42 PM EDT - 9 months ago

REGENXBIO Inc. (RGNX) Q1 2024 Earnings Call Transcript


REGENXBIO Announces Proposed Public Offering of Common Stock

Mar 6, 2024, 4:10 PM EST - 11 months ago

REGENXBIO Announces Proposed Public Offering of Common Stock


REGENXBIO Inc. (RGNX) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 9:45 PM EST - 11 months ago

REGENXBIO Inc. (RGNX) Q4 2023 Earnings Call Transcript